In this regard, anti-programmed cell death 1 (PD-1)/PD-L1 and anti-cytotoxic T lymphocyte-associated protein 4 (CTLA-4) therapies have been demonstrated to elicit dramatic tumor regression in some patients [4]. This evidence concerns the gene PDCD1 and neoplasm.